Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.
about
Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal diseaseSafety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adultsReview of meningococcal vaccines with updates on immunization in adultsCritical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive diseaseNCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivorsImmunoinformatics Approach in Designing Epitope-based Vaccine Against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b).Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responsesPaediatric travel medicine: vaccines and medications.Meningococcal polysaccharide A O-acetylation levels do not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine: results from a randomized, controlled phase III study of healthy adults aged 18 to 25 years.Vaccination of travelers: how far have we come and where are we going?MenACWY-TT vaccine for active immunization against invasive meningococcal disease.The Long Road to an Effective Vaccine for Meningococcus Group B (MenB).Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.Fighting Neisseria meningitidis: past and current vaccination strategies.Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia.Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.
P2860
Q27028161-8ED99500-15E8-424E-A19E-5DB090EA198CQ28744376-7532D66E-1F22-4C5F-B32D-6F1A80ADC781Q28828692-80C8A4A9-8898-4448-A99E-17505EBE0EAFQ35187182-0AA8FAC0-8049-491F-953A-F1032805ACA2Q35661304-84608422-4FCE-403A-A497-44554545A2D6Q36182445-6070817D-E61F-40FF-908C-2A45E90E3907Q36803269-65996C58-00FD-4650-9296-8EB70D594E56Q36948104-9D6AEC8D-7A6E-4221-9BE9-02AF035BB0F2Q37252405-44258A44-FB1F-4F14-BB55-3BA1D772DD49Q37951528-4F20935A-EC1C-4A72-ABAA-3366CC08A410Q38028992-03E9BE87-57EC-47B0-9E42-D84B88BECA02Q38335257-181A8AB5-3B3E-487B-8377-BB3EF39E85D7Q38363907-67C3AECD-DF50-4B04-B0E1-F009FD01841FQ38829564-AA5E3CCC-2725-4B4B-B9C5-C43C746AFC32Q38867479-6EE6B2DA-321B-494A-B700-91CD41C424D2Q41648169-64617DE6-0EBB-4755-9355-54522EBB49A9Q51716182-31D64E79-3C1A-4C67-94BD-06E65CFFA701Q54255446-89BD7D1A-4091-45DF-B679-9319A106527D
P2860
Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@ast
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@en
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@nl
type
label
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@ast
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@en
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@nl
prefLabel
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@ast
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@en
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@nl
P2093
P2860
P356
P1476
Menveo®): a novel quadrivalent ...... serogroups A, C, W-135 and Y.
@en
P2093
Brian Cooper
Jeffrey Stoddard
Lisa DeTora
P2860
P356
10.1586/ERV.10.147
P577
2011-01-01T00:00:00Z